Bruker (BRKR) Dividends Paid - Common Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 7.25% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.87% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.26% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Bruker | 8.89 Bn | 8.77 Bn | 379.80 Mn | 14.13% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.13% |
| Dec 31, 2025 | 0.45% |
| Sep 30, 2025 | 0.89% |
| Jun 30, 2025 | 0.44% |
| Mar 31, 2025 | 0.88% |
| Dec 31, 2024 | -79.33% |
| Sep 30, 2024 | -25.26% |
| Jun 30, 2024 | 48.31% |
| Mar 31, 2024 | 6.17% |
| Dec 31, 2023 | 6.17% |
| Sep 30, 2023 | -24.65% |
| Jun 30, 2023 | 27.24% |
| Mar 31, 2023 | 6.08% |
| Dec 31, 2022 | 6.08% |
| Sep 30, 2022 | 6.08% |
| Jun 30, 2022 | 5.98% |
| Mar 31, 2022 | 5.98% |
| Sep 30, 2021 | 52.82% |
| Jun 30, 2021 | -43.97% |
| Mar 31, 2021 | -1.07% |
| Dec 31, 2020 | -37.43% |
| Sep 30, 2020 | 50.47% |
| Jun 30, 2020 | -128.94% |
| Mar 31, 2020 | -1.05% |
| Dec 31, 2019 | 35.30% |
| Sep 30, 2019 | 106.90% |
| Jun 30, 2019 | -1.04% |
| Mar 31, 2019 | -1.04% |